Tuesday, November 5, 2024
HomeTagsROR1-targeting

ROR1-targeting

CStone Pharmaceuticals announced the IND approval of CS5001, a potential global best-in-class ROR1-targeting ADC by the U.S. Food and Drug Administration

CStone Pharmaceuticals, a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics